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Introduction
At the onset of the millennium, China's State Council has decided to accelerate economic development through innovation, high-technology, and industrialization (Liu et al. 2011 ). Research and development (R&D) operations have increasingly been relocated from public research institutes to firms in state and non-state sectors to increase China's general scope of industrial R&D and to contribute to the economy's technological sovereignty ). In addition, the government has provided substantial funding, in particular to inventive high-tech firms which are supposed to become main drivers of China's technological trajectory.
From 2001 to 2006, China's public support for industrial innovation amounts to 450 billion RMB, with two-thirds coming from R&D funds, and contributed 60% to industrial R&D investments (Ministry of Finance (MOF) 2014). Throughout the same period, the industrial contribution to China's gross expenditures for R&D has been increasing from 60% to 71%. Measured as a ratio to GDP, industrial R&D investments accelerated from 0.58% to 0.99% and gross R&D expenditures improved from 0.95% to 1.39% (MOF 2014, National Bureau of Statistics (NBS) 2014).
Although these figures suggest an increase in industrial R&D in relative and absolute terms, the effect of China's R&D subsidies remains unclear. As pointed out by Arrow (1962) , due to market failure in the production of knowledge R&D investments of firms may remain below the social optimum and require correction by public subsidies. However, if the effect of government subsidies on firms' own R&D investments is negative or not significant then the economic justification for continuing support in its existent form is considerably undermined.
In China's case, the recurrent underachievement of national R&D targets throughout the last decade indeed questions the effectiveness of policy measures employed and thus requires a 1 careful examination of the effectiveness of China's R&D subsidies on industrial R&D investments. 1 Because prior studies on China's R&D subsidies are small in numbers and often suffer from methodological limitations, we aim to contribute new evidence to the literature. We estimate the effect of receiving R&D subsidies by investigating differences in own R&D investments of recipients and otherwise comparable non-recipients over time. To control for selection bias in the distribution of grants we derive robust estimates by combining nonparametric propensity-score matching (PSM) with a difference-in-differences (DID) estimator.
This econometric strategy is employed to a unique panel on the population of Chinese listed firms, observed throughout the time period 2001 to 2006. We match firm level data from annual reports with numerous data sources, including patent data from the European Patent Office's Worldwide Patent Statistical Database (PATSTAT) and export data from Chinese Customs. An exhaustive set of variables is operationalized to explain which firm characteristics actually determine the allocation of R&D subsidies. Because inventiveness and high-tech orientation of firms are supposed to accelerate China's technological trajectory, we place particular emphasis on these characteristics.
We briefly foreshadow our findings. For allocation, we find that firm participation is determined by high quality inventions whereas high-tech sector affiliation is less important.
Further, our results show persistence in receiving R&D subsidies. Against the background of transition from a centrally planned to a mixed market economy, we take interest in implications for grant distribution which, until now, have not been studied in the literature.
Regarding the influence of state-ownership, we find that minority state-owned firms are more likely to become recipients than majority state-owned and private-owned firms. Provincial 1 China's 9 th and 10 th "Science and Technology Development Plan" specify target ratios of 1.5% for gross R&D expenditures to GDP in 2000 and 2005 but actual ratios reached were 0.90% and 1. 35%. variation in China's transition towards a market-driven economy reveals that R&D subsidies are less often distributed by more market-oriented provincial governments and that China's innovation policy of "picking the winners" is more supportive of firms located in developed provinces.
Considering effectiveness, we find that R&D subsidies instantaneously crowd-out firms' own R&D investment but are neutral in later periods. For example, in 2006 one public RMB reduces firms' own R&D investments by half a RMB. This implies that public subsidies fail to correct industrial R&D towards the social optimum but cause partial crowding-out instead.
For repeated recipients, high-tech firms, and minority state-owned firms we identify instantaneous neutral effects. Nonetheless, the overall economic justification for China's R&D programs throughout the time period 2001 to 2006 is questionable since we fail to identify additionality effects. Against this background, we acknowledge that the "Medium-to Long-term Plan for Science and Technology Development (2006-2020) " has provided considerable changes to China's innovation policy and future research should examine whether the effectiveness of R&D subsidies has improved after 2006.
The remainder of this study is structured as follows. In Section 2 we discuss the rational for R&D subsidies and review prior studies. Against China's institutional background, implications for the allocation and effectiveness of R&D subsidies are derived. In Section 3 we explain the econometric methodology employed. Section 4 introduces the data and provides descriptive statistics. Section 5 contains the main results, robustness tests, and further investigations. We provide concluding remarks in the final section.
Previous Literature
The seminal argument for R&D subsidies has been provided by Arrow (1962) . Due to market failure in the production of knowledge, R&D investments of firms may remain below the social optimum and require correction by public subsidies. The crucial question is whether the government is able to select those R&D projects with high social returns which firms would not fund by themselves. R&D subsidies encompass two main policy instruments, tax incentives and direct subsidies (David et al. 2000) . The primary difference is that the former allow for firm selection of R&D projects, whereas the latter typically are accompanied by government selection.
In our study we are concerned with the effect of direct R&D subsidies on firms' own R&D investments. In contrast to firms' gross R&D investments, own R&D investments correspond with net R&D investments which remain once firms' gross R&D investments have been corrected for R&D subsidies received. Figure 1 presents the taxonomy of subsidy effects -ranging from crowding-out over neutrality to additionality. In the situation of additionality, grants are complementary to own funds and increase net R&D expenditures.
This outcome might be caused by several mechanisms: (1) R&D programs require the recipient to match public funds with own funds, (2) a subsidized project involves setting up of research facilities, lowers fix costs of other current or future projects, and thus turns those into profitable investments and (3) expertise gained throughout a subsidized project might positively influence the profitability of non-subsidized projects.
Full crowding-out occurs when public funds are perfect substitutes to own funds and decrease net R&D expenditures. In this case, matching requirements fail to prevent substitution of own funds by public funds because it is unknown to the government whether the selected project would have been undertaken without support. Even if a firm had not initiated a project without public support the recipient may readjust its portfolio of projects and allocate funds from dispensable projects towards the supported one. Funds released by subsidies might be used partially or totally for new R&D projects but could also be expensed for non-R&D purposes. Consequentially, subsidies may also result in partial crowding-out or neutrality.
Using firm level instead of project data blurs insights into the rearrangements of project portfolios and thus limits the identification of the precise mechanism through which the firm changes its net R&D expenditures (Lach 2002) . Nonetheless, we can make inference about changes in net R&D spending of recipients, which is essential information for policy makers.
If the direct effect of government grants on firms' own R&D investment is negative or not significant, then the economic justification for continuing the support of industrial R&D in its existent form is considerably undermined.
Prior Studies
A steadily growing literature has empirically examined the effects of R&D subsidies and provides conflicting evidence. David et al. (2000) report that one-third of those studies conducted before 2000 fail to reject crowding out. Similarly, Zuniga-Vicente et al. (2014) report that one-fifth of more recent firm level studies fail to reject crowding out, while 17% report neutrality and the remaining 63% find evidence for additionality. In summary, this points to context specific effects of R&D subsidies, depending on the country and time period.
More recently, the literature has started to consider temporal aspects of R&D subsidies and confirms persistence in grant distribution (Bloch & Graversen 2008 , Gonzales & Pazo 2008 . Persistence might arise due of various reasons: (1) because prior recipients might benefit from information advantages in subsequent applications, these firms not only select themselves more often into the application process but also exhibit higher probabilities of filing successful applications, (2) governments may repeatedly select prior recipients to maximize the success rate of a policy, and (3) persistence might be increased by R&D projects which span multiple time periods. However, investigations of the effectiveness of prior subsidies on R&D expenditures are still scarce. For German manufacturing firms, Hussinger (2008) confirms additionality and Aschhof (2009) finds additionality for frequent recipients but neutrality for first-time receivers.
There might be several reasons why a grant shows no instantaneous but a lagged effect on R&D investments: (1) the adjustment of a firm's R&D portfolio might be time consuming so that the full effect only emerges with delay, (2) a subsidized project may lower the fix costs of future projects, and thus turns those into profitable investments, and (3) learning throughout a subsidized project might increase the success of upcoming R&D projects. However, for lagged effects the prior evidence remains inconclusive. Investigating Israeli manufacturing firms, Lach (2002) finds an instantaneous crowding-out effect and a lagged neutrality effect.
For Norwegian high-tech industries, Klette & Moen (2012) find both, weak evidence for lagged additionality as well as lagged neutral effects, depending on the econometric specification.
Notwithstanding that R&D programs are not exclusively employed in developed countries, the limited number of studies for emerging countries presents equally inconclusive evidence (for examples see Kwon & Ko 2004 and Lee & Cin 2010 for Korea and Özcelik & Taymaz 2008 for Turkey). In the following, we review the evidence derived from Chinese firm-level data, including studies published by Chinese language journals.
2 Because we take interest in reactions at the firm level, we exclude studies at the industry level and disregard firm level studies which employ industry level subsidy data. Finally, our review includes ten studies concerned with China, seven in Chinese language and three in English language, as summarized in Table 1 .
We briefly report the main insights of our survey. Surprisingly, only one out of ten studies fails to reject crowding-out in China which is in stark difference to those surveys summarizing research conducted in developed countries. In comparison with one-third of the earlier studies surveyed in David et al. (2000) and one-fifth of the more recent literature explored in Zuniga-Vicente et al. (2014) , one-tenth is an unexpectedly low ratio for China's R&D subsidies. Our skepticism is shared by Naughton (2007, p. 368) , who rejects overly positive results of China's innovation policy as counterintuitive. In addition, Hu & Jefferson (2008) are skeptical that the abrupt increase in industrial R&D observable throughout the early 2000s has been driven by government funding and Guan & Yam (2014) show that direct subsidies have failed to enhance innovative economic performance of firms in Beijing throughout the 1990s. Tian & Yu (2012) point out that the government or scientific community might influence Chinese journals to select politically satisfactory evidence for publication. Although we cannot observe ex ante selection, for those studies in our review, methodological issues, not the journal's language, seem to be decisive.
As criticized by David et al. (2000) , many studies ignore endogeneity problems by assuming random selection in grant distribution. However, this assumption is assuredly rejected for the selective support of inventive high-tech firms pursued by China's R&D programs. Firstly, these firms are likely to have higher R&D spending than other firms and, secondly, confounding characteristics which affect R&D spending may affect grant distribution as well. Thus, receiving a grant becomes endogenous to the firm's own R&D efforts. In other words, even in the hypothetical absence of government grants the R&D expenditures of recipients are likely to be higher than those of non-recipients, leading to an overestimation of the actual subsidy effect. Thus, our review shows that prior studies fail to provide conclusive evidence for the allocation and effectiveness of China's R&D subsidies. We aim to fill this gap. Against
China's institutional background of an emerging and transitional economy, in the following section, we derive implications which are addressed in the subsequent analysis. Springut et al. 2011) . Because of China's distinctive reforms, provincial governments have emerged as powerful regulators of firms in their jurisdictions (Tenev et al. 2002) . Half of China's spending for science and technology, including R&D programs, takes place at the subnational level -emphasizing the importance of provincial governments in innovation policy (Springut et al. 2011 ). Therefore, de facto implementation of China's R&D programs might deviate from the blueprints of the central government.
China's R&D Subsidies and Institutional Background
On the grounds of Arrow's (1962) seminal argument advocating a correction of R&D investments by public subsidies, the government takes the role of a regulator with the ambition to reduce market failure in the production of knowledge by private firms. Against the background of China's transition from a centrally planned to a mixed market economy, the government not only takes the regulator's role for private-owned firms but also acts as a majority or minority shareholder within China's numerous state-owned firms.
During China's planned economy, the government directly commanded state-owned firms with little need for supplementary employment of R&D subsidies (Holz 2003, p. 270) .
However, referring to the ongoing separation of regulation, ownership, and management within China's state-owned firms, Lee and Hahn (2004) point to the rise of principal-agent and corporate governance issues. While the process of separation may, on the one hand, increase the government's willingness to employ R&D subsidies within the state sector, on the other hand, it might limit monitoring mechanisms and give rise to the abuse of public funds for non-R&D purposes (Ding 2000) .
Meanwhile, many former majority state-owned firms have been transformed into minority state-owned firms with managers becoming owners, e.g. major shareholders. This transformation also corresponds with a reduction of direct governmental influence on firms but, unlike within majority state-owned firms, introduces managers as additional owners that are concerned with the long-term competitiveness of their firms (Tenev et al. 2002) .
Therefore, the transformation into a minority state-owned firm may increase the government's need to employ R&D subsidies in order to supplement its diminishing potential of direct command. In addition, the corporate governance setting within minority state-owned firms appears to be beneficial for an effective use of R&D subsidies since major shareholders share the government's ambition to raise firms' R&D investments.
With respect to the increasing number of private-owned firms operating in China's economy, the government's function is by and large reduced to regulatory issues while mechanisms of direct command remain formally restricted to the state sector. In contrast to the state sector, the private sector is determined by fierce competition as well as hard budget constraints and private firms often pursue short-term profit maximization at the expense of uncertain R&D investments with high capital lockup (Naughton 2007, p. 309) . Against this background, the private sector's potential in increasing China's industrial R&D investments appears ambivalent and these firms' commitment to policy targets is low. Although privateowned firm may be in greater need of financial support the actual utilization of funds within these firms remains uncertain -decreasing their attractiveness as recipients from the regulator's perspective. Reversely, private-owned firms might also refrain from participation in public R&D programs because they like to avoid government interference in their business operations. In summary, China's economic setting offers the unique opportunity to study how allocation and effectiveness of R&D subsidies are influenced by firm ownership and related command mechanisms.
Progress in the transition from plan to market is not taking place uniformly but exhibits a pattern of provincial variation across China (Fang et al. 2007) . Provincial governments follow different economic strategies as observable in varying degrees of governmental resource allocation in proportion to provincial GDPs. However, it remains unclear how increasing market-orientation might affect the distribution of grants. Since more marketoriented provincial governments are confronted with a higher probability of market failure within their jurisdiction, this may require correction through frequent employment of R&D subsidies. Reversely, more market-oriented governments might employ grants precisely less often in order to limit incidences of economic intervention. This pattern of provincial variation in China's ongoing economic transition allows us to study if marketization is accompanied by a more or less frequent employment of R&D subsidies to address potential market failure in the production of knowledge.
Marketization and economic development are related but not identical concepts. With respect to China's regional economic disparities, Xu (2011) argues that policies of the central government in general favor the support of China's developed coastal regions. Indeed, firms located in developed regions may more easily access crucial resources required for successful R&D operations, which makes them more promising recipients than firms found in China's backward regions. In conclusion, beyond the focus on inventive high-tech firms specified in the central government's policy blueprints, firm ownership, differences in economic strategies of provincial governments, and regional economic disparities might influence the allocation and effectiveness of R&D subsidies in China.
Econometric Method
The crucial problem in evaluation studies is that grant distribution is mostly not random, but the government may select recipients according to political priorities and certain types of firms might self-select into the application process. To avoid selection bias, the evaluation literature presents a variety of methods, such as instrumental variables techniques, selection models, PSM, or DID (for surveys see Blundell & Costa-Dias 2000 , Cerulli 2010 , and Heckman et al. 1999 . We follow the suggestion of Blundell and Costa-Dias (2000) who argue that a combination of non-parametric PSM with a DID estimator is likely to provide robust results. Indeed, the properties are complementary, because the first relaxes the common trend assumption of the latter, while the DID estimator accounts for time-invariant unobservable firm heterogeneity which is neglected by PSM. With respect to the evaluation of R&D subsidies, this econometric strategy has been applied by Goerg et al. (2008) and Goerg & Strobl (2007) for panel data and by Aerts & Schmidt (2008) for repeated cross-sections.
The average treatment effect on the treated can be expressed as:
where and denote the outcome variables, in our case R&D expenditures, in the treated 'T' and counterfactual 'C' situation. The treatment status, in other words the receipt or non-receipt of R&D subsidies, is indicated by ∈ {0,1} . Thus is calculated as the difference of the actual outcome in the case of treatment with the potential outcome in the counterfactual situation.
While the actual outcome ( � = 1) can be calculated by the sample mean of the outcome in the treatment group, the counterfactual situation � � = 1� is not observed in the data. Naïvely assuming that the average outcome of the counterfactual situation equals the average outcome of the non-treated group:
might lead to selection bias if the allocation of treatment is non-random. In our setting, China's "picking-the-winner" innovation policy aims to selectively support inventive and high-tech firms which might have higher R&D expenditures than non-inventors or non-hightech firms. 3 Therefore, the confounding variables which affect the distribution of R&D subsidies also affect the firm's R&D expenditures and thus receiving a treatment becomes endogenous to the firm's R&D. Consequently, even in the hypothetical absence of treatment the R&D expenditures of treated firms are likely to be higher than those of non-treated firms, leading to an overestimation of the actual treatment effect.
Propensity Score Matching
PSM is a non-parametric estimator which requires no particular functional form. It matches treated and non-treated observations with similar confounders and thereby identifies a non-treated control group with the same likelihood of being treated as the actually treated group. Because the only remaining difference between both groups is the treatment, the difference in outcomes finally can be attributed to the treatment. However, PSM relies on relatively strong assumptions and is data-demanding with regard to the operationalization of relevant confounding variables.
First and most generally, the stable-unit-treatment-value assumption (SUTVA) is satisfied if the outcome takes a single value, instead of following a distribution, and if the treatment of one firm does not affect the treatment effect on another firm (Rubin 1990 ). Secondly, the conditional independence assumption (CIA) needs to be invoked which states that the receipt of treatment and potential outcomes is independent (∐) for those firms with the same set of characteristics = (Rubin 1977) :
The CIA is only satisfied if all confounding variables are known and observable in the data. Unfortunately, the validity of SUTVA and CIA cannot be tested. However, based on the rich data observable to us we argue that enough information is given for the operationalization of confounders. Thirdly, the common support condition (CSC) demands that for all treated observations, a control-observation should be found in the sub-population of non-treated observations. In other words, it rules out that the treatment is perfectly predictable (0,1) based on the observables and ensures that firms with the same characteristics have a positive probability of receiving or not receiving the treatment (Heckman et al. 1999) :
The CSC requires that there are no regions where either treated or control observations have zero probability to occur (for example if firms with a specific attribute included in are strictly excluded from participation in R&D programs). In addition, we can fulfill the CSC by removing observations on treated firms with probabilities larger than the maximum and smaller than the minimum probabilities of those observations in the potential control group.
Consequently, the average treatment effect on the treated could be estimated as:
The PSM estimator specifically addresses the issue of the CSC. Matching treated and nontreated observations might become complicated due to different dimensions or weighting schemes which may be applied for different firm characteristics in . Fortunately, Rosenbaum & Rubin (1983) show that if CIA is satisfied, then not only two treatments are independent of the assignment conditional on X but also on specific functions of X, denoted as the propensity score � ( ). Thus, the so-called 'curse of dimensionality' can be overcome by the use of propensity scores generated from modeling the probability of receiving a treatment.
The accuracy of matching can be improved by conditioning on a subset of , also known as imposing stratification criteria, as done in our study. We perform nearest neighbor matching with replacement and allow the same control observations to be matched to different treated observations. This replacement offers a large pool of potential controls but also causes a bias in the t-statistic on mean differences which is corrected for according to Lechner (2001) . Our matching technique follows the routine by Czarnitzki & Lopes-Bento (2013) -for further details see the Matching Protocol in the Appendix. Finally, after performing PSM we can estimate the average treatment effect on the treated:
Difference-in-Differences Estimator
As argued in Blundell and Costa-Dias (2000) , the PSM estimator still crucially rests on the CIA. Despite comprehensive data, it still seems unreasonable to believe that we can observe all firm characteristics which determine the distribution of R&D subsidies and R&D expenditures. The CIA between the error term in the outcome equation and the treatment is quite strong if one considers that firms might select themselves according to their forecasted outcome. Consequently, we combine PSM with a DID estimator and are thus able to control for time-constant firm-specific effects in the unobservables.
Nonetheless, Goerg & Strobl (2008) point out that the DID estimator might become inconsistent if firms apply for a R&D subsidy and also increase their R&D expenditures regardless of the treatment. If this phenomenon is symmetrically distributed between recipients and non-recipients, then this issue should not be of concern. If, however, this is more common for recipients, then the subsidy effect is likely to be overestimated because the increase in R&D expenditures is not fully caused by the treatment. Even though this issue cannot be completely ruled out, we argue that our data is sufficiently rich so that no additional time-variant unobservables that may be correlated with the treatment and the outcome.
The DID requires panel data and compares the change in the outcome for treated observations with the change in the outcome of the counterfactual observations according to ∆ − ∆ , where ∆ is a time-differencing operator over 0 to 1 . The DID outcome equation can also be expressed as ∆ = + ∆ + , while the average treatment effect on the treated is estimated as follows:
Finally, we combine the advantages of the PSM estimator with the advantages of the DID estimator. Thereby, we ensure that the treatment group and the control group are chosen according to observable confounders , while common macroeconomic trends and constant firm-specific unobserved effects are controlled for as well. We estimate the average treatment effect on the treated according to our final specification: Initially, our raw data includes information on 1,458 firms and 7,853 observations. We exclude 11 firms with a holding structure and 12 firms from the financial sector. Hereafter, we first eliminate measurement errors and missing values and then exclude outliers above the 99 th percentile for our R&D outcome variables. We remain a sample with 1,331 firms and 7,008 observations. As required by our estimation strategy, we calculate first-differences for the outcome and treatment variables and lag treatment variables by two time periods in order to be able to estimate lagged effects of R&D subsidies for up to two time periods. After again eliminating observations with missing values, our estimation sample includes 1,155 firms with 4,139 observations. Notably, we are aware of concerns regarding the quality of Chinese data in general and of subsidy data in particular (Haley & Haley 2013 ). Since the firm-level data used in this study leaves fewer room for data fabrication than aggregated data and the financial statements of 11 It should be noted that China's measure of R&D is more broadly defined than the typical R&D measure used by the OECD and most of the R&D literature (Jefferson et al. 2003) . The broader concept applies to both, R&D subsidies and R&D expenditures and, in addition to R&D expenditures, involves a range of science-and technology-related expenses. In the remainder of this study, we continue to refer to R&D. listed firms are scrutinized by accounting agencies, we are less concerned regarding data quality (Orlik 2011 ). In addition, we test the quality of subsidy information based on the ad valorem distribution of China's export subsidies. For exporting firms, we regress export subsidies on total exports and a set of controls and find that firms' export volume is positive and highly significant (p-value < 0.001) in explaining the amount of export subsidies received. 12 This result confirms the expected relationship between export subsidies and exports volume and thus leaves us with no particular reason for skepticism with respect to data quality.
Descriptive Statistics
Following the objectives of China's innovation policy, we consider firm inventiveness and high-tech orientation as important determinants for grant distribution. In addition to standard firm characteristics, we operationalize a set of confounding variables to control for heterogeneity in ownership, resource allocation by provincial governments, as well as regional economic disparities. Table 2 provides descriptive statistics.
Subsidies are conceptualized as binary variables to meet our methodological requirements.
R&D subsidies are distributed to 10% of observations. Acknowledging persistence in the allocation of subsidies, we control if a firm had received R&D subsidies or other subsidies within that last 2 years prior to the treatment. R&D subsidies had previously been distributed to 11% of observations while 44% of observations have received non-R&D subsidies throughout the last 2 years. These statistics suggest that R&D subsidies are allocated less often than non-R&D subsidies received by firms.
A firm is identified as an inventor if it has a positive patent stock. 13 This might appear as a low benchmark but sufficiently discriminates between Chinese inventors and non-inventors The general high-tech orientation of a firm is operationalized based on the industrial hightech classification. In our sample, 16% of observations belong to high-tech industries.
However, we expect considerable heterogeneity between the actual high-tech orientations of these firms. Therefore, we calculate the high-tech export intensity as non-processing hightech exports weighted by the firm's revenue. Processing export is excluded because Chinese firms often only assemble imported high-tech inputs for overseas export markets but add little value to the final product (Wang & Wei 2010) . The average high-tech export intensity for exporting firms is 4%
Based on ownership shares held by the government, we discriminate between majority state-owned firms ( > 50%), minority state-owned firms (50% ≥ > 0%), and privateowned firms ( = 0%). 33% of the observations are majority state-owned firms, while 39% are minority SOEs, and 29% are Private-owned firms.
14 13 Precisely, the patent stock in year t is the patent filings of that year plus the patent stock in year t-1 depreciated by 15%. To control for firm size, we weigh the patent stock by the number of employees. 14 For each ownership type we calculate the share of treated observations and find that majority state-owned firms exhibit half the probability of receiving R&D subsidies compared to minority state-owned firms and private-owned firms. We interpret this finding as preliminary evidence for our consideration that the government's direct influence on majority state-owned firms decreases the need for additional intervention by R&D subsidies.
Heterogeneity in provincial transition towards a market-driven economy is measured by the NERI index based on the resource allocation by provincial governments in proportion to provincial GDPs. For the base year 2001, the NERI index is normalized on a scale ranging from 1 to 10, with 10 indicating the province with the highest level of resource allocation by the market and 1 indicating the province with the highest level of resource allocation by the government. The remaining 29 provinces receive scores in between, according to their relative performances. In subsequent years the index may take values outside the base scale to account for differences between provinces and over time. Observations in our sample have a mean index of 7.93, suggesting that the majority of firms are located in provinces administered by more market-oriented governments. China's regional variation in economic development is measured by the log of provincial GDP per capita.
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We briefly summarize the operationalization of standard controls. Firm size is measured by the log of the number of employees while the capital intensity is measured by taking the log of net fixed assets divided by the number of employees. Profitability is a binary variable taking the value of 1 if the firm's net profits are positive. We classify a firm as an exporter if it exhibits exports in the respective year. The log of the number of years since establishment informs us about the age. In addition, we use 21 industry dummies to control for industryspecific characteristics. Because 62% of firms operate in manufacturing, we use a set of finer industry controls for the manufacturing sector. Table 3 shows the industry composition and the number of subsidized firms per industry.
Our main output variable is R&D intensity. We operationalize R&D intensity based on gross and net R&D expenditures weighted by revenue. For R&D performers the gross and net R&D intensity is 0.75% and 0.73% respectively, which is similar to the average gross R&D intensity of 0.76% for China's large-and medium-sized throughout this time period (NBS & 15 Note that the market orientation of provincial governments and provincial economic development are interacting but different concepts as confirmed by the low correlation coefficient of 0.266.
MOST 2007). For later robustness tests, we also calculate the R&D stock according to the perpetual investment method. 16 The mean value for the R&D stock weighted by the capital stock is 6.64%.
17
Employing a Probit model with standard errors clustered at the firm level, we regress the decision to conduct R&D on our main confounders and standard firm characteristics. Indeed, we find that inventors and firm in high-tech sectors have a positive and highly significant (p < 0.001) probability to conduct R&D.
Empirical Results

Allocation
In Table 4 , we present four Probit estimations for the likelihood of receiving R&D subsidies. All time-varying firm level regressors, except age which we consider as truly Model (1) presents a parsimonious specification without controls for prior subsidies and industry affiliation. Beginning with firm inventiveness, we find that the patent stock is negative but insignificant while the patent citation intensity is positive and significant at the 1% level. For high-tech industry affiliation, we find a positive effect at the 5% significance level while the high-tech export intensity is negative and insignificant. These finding suggest that it is not the quantity but the quality of inventions determines selection and that affiliation with the high-tech sector instead of the intensity of high-tech exports is relevant.
For ownership, we find that both minority state-owned firms and Private-owned firms have a significantly, at the 1% level, higher probability of receiving grants compared to majority state-owned firms. Firms located in jurisdictions of provincial governments which are more market-oriented have a significantly lower probability of receiving grants.
Conversely, firms located in more developed provinces have higher probabilities of receiving grants, both at the 1% significance level. For the set of standard controls, we find that profitability, export status, and age are positive and significantly correlated with receiving R&D subsidies. These findings fit well into China's innovation policy of "picking the winners".
In Model (2), we include industry controls. 18 The results remain largely unchanged except that high-tech industry affiliation and export status turn insignificant. These changes are plausible, since both of these criteria are largely explained by industry characteristics which are now controlled for.
Model (3) presents our final specification and includes additional information on prior R&D subsidies and prior non-R&D subsidies. We confirm persistence in grant distribution for both subsidy categories at the 1% significance level. Note that the inclusion of prior subsidies increases the models' goodness of the fit (pseudo R2) from 0.08 in Model (2) to 0.28 in Model (3). Since prior subsidies capture information about firm characteristics which have previously led to successful applications, the explanatory power of remaining regressors is reduced. This reduction also applies to industry controls, as revealed by an increase in the pvalue of the chi2-test from 0.12 in Model (2) to 0.57 in Model (3).
18 Note that by including industry controls we lose 53 observations from mining and 12 observations from wood & furniture manufacturing since these industries have zero probability of receiving R&D subsidies in our regression sample.
In addition to prior subsidies, the following characteristics remain significant with respect to the probability of receiving R&D subsidies: patent citation intensity, minority state ownership, resource allocation by provincial governments, and provincial economic development. For these regressors we calculate average marginal effects as a change from 0 to 1 for discretely distributed variables and as an increase of one standard deviation from the mean for continuously distributed variables. Against an average probability of 11.67% to become a recipient, we calculate corresponding changes in percentage points: prior R&D 36.44, prior non-R&D subsidies 5.04, patent citations intensity 10.40, minority stateownership 3.36, market orientation by provincial government -3.98, and provincial GDP per capita 2.87.
In line with the literature, we confirm persistence in receiving R&D subsidies. In addition, our findings suggest that grants are indeed distributed to firms with previous high quality inventions. Further, minority state-owned firms are more likely to become recipients. As discussed before, a large share of China's spending for science and technology is allocated by subnational governments which often hold shares in minority state-owned firms whereas majority state-owned firms are commonly associated with the central government. Minority state-owned firms may be frequent recipients because of the government's lesser degree of direct influence, compared to governance by edicts in the case of majority state-owned firms, and the subnational governments' preference to distribute its resources to those firms in which they held ownership shares. In addition, the regulator might anticipate a higher effectiveness of R&D subsidies in minority state-owned firms because owner-managers in these firms may share a long-term motivation to increase R&D investments which differs from the short-term profit-orientation of private-owned firms.
On the provincial level, we can confirm that more market-oriented governments also limit the instances of intervention by R&D grants. Conversely, governments more directly involved in resource allocation also favor active regulation and employ R&D subsidies more often. Based on the propensity scores obtained from Model (3), we perform nearest-neighbor matching and match every treated observation with the most similar control observation from the pool of potential control observations. As common support is a necessary condition for the validity of the matching estimator, we exclude 6 treated observations because no common support could be found. To improve the accuracy of the match, we require exact matching for the following stratification criteria: time periods, prior R&D subsidies as well as inventor, high-tech, and ownership status. Although the p-value of the chi2-test in Model (3) confirms that industry controls have no joint significance in explaining the allocation of R&D subsidies, we require a precise separation between manufacturing and non-manufacturing firms. For later analysis, by restricting the maximum distance between neighbors to a tolerance level of 0.1, we disregard another 134 observations. From the pool of control observations 95% are used not more than three times and 68% are only used once throughout the matching process. Table 5 and Table 6 present means, standard deviations, and the p-values of the t-test on mean differences for all regressors and propensity scores before and after matching. Before matching, 11 out of 15 regressors have significantly different means. After matching, the pvalues of the t-tests on mean differences indicate that no significant differences remain.
Accordingly, t-tests on mean differences between propensity scores show that p-values increase from < 0.001 to 0.992. As a final test, Model (4) in Table 4 re-estimates Model (3) with the matched data and confirms that no single regressor remains significant in explaining the allocation of R&D subsidies, while pseudo R2 is reduced from 0.28 to 0.02 accordingly.
Effectiveness
After studying grant allocation, we investigate the effect of R&D subsidies on own R&D investment of firms based on the following outcome equation: = + + . In accordance with our econometric strategy, outcome is measures by net R&D intensity while treatment enters the equation as a binary operationalization of R&D subsidies. 19 We do not
This setting enables us to estimate the subsidy effect for recipients in comparison to similar non-recipients with a probability of receiving the subsidy. Because we are methodologically intrigued by the question in how far the reduction of selection bias changes the perceived effectiveness of the treatment, we start with an OLS estimator. 20 Under the naïve assumption of random selection, we identify a positive effect of R&D subsidies, which is significant at the 5% level. This result reflects the additionality reported by prior studies on China which simply ignore the issue of selection bias.
Hereafter, we re-estimate the outcome equation with the matched sample to rule out selection on observables. 21 The effect of R&D subsidies turns negative and insignificantsuggesting neutrality. This result is similar to the findings of Cheng & Chen (2006) , who draw the same conclusion for private firms in Zhejiang province after performing nearestneighbor matching. Based on the matched sample, we finally adjust the outcome equation by taking first-differences ∆ = + ∆ + to rule out selection on observables and on time-constant unobservables. We obtain a negative treatment effect, significant at the 1%
19 Although we observe the amount of R&D subsidies we only consider the incidence of treatment instead of treatment intensity. Calculating the subsidy effect for K different levels of treatment intensity would require a split of recipients' observations into K+1 treatment groups and corresponding control groups. However, for this exercise the number of available observations is too small and would result in poor matching results as well as less robust DID estimations. 20 Note that the OLS estimation is based on the complete sample with 7,008 observations. All following estimations rely on the matched sample with 686 observations. This sample has non-missing observations for first-differences of the outcome and treatment variable as well as non-missing observations for 1 and 2 period lags of the treatment variable. By performing all estimations with the same sample we rule out that results are influenced by the selection of observations. 21 For all estimations in this section we calculate bootstrapped standard errors (using 500 replications) as suggested by Lechner (2002) , since the repeated use of control observations in the matching procedure makes the calculation of the actual estimation variance more complicated.
level, which suggests partial or full crowding-out. Speaking in favor of our econometric strategy, starting from a naïve OLS estimation the stepwise elimination of selection bias based on observables by PSM and additionally on time-invariant unobservables by DID considerably changes the results of the three specifications. The following analysis relies on the last specification to eliminate selection bias to the largest extend.
In Table 8 we focus on potential differences between instantaneous and lagged effects.
The coefficients for R&D grants lagged by 1 and 2 periods turn positive but insignificant and decline in magnitude, suggesting neutrality in later periods. These findings are similar to the results presented by Lach (2002) for Israel and Lv & Yu (2011) for China. Thus, it seems that public funds instantaneously reduce own R&D investment of firms but have no effect on the funding of R&D projects in later periods -suggesting that firms use R&D subsidies for an immediate reduction of their own expenses for R&D while keeping their R&D portfolio unchanged.
Having obtained these results, in Table 9 we provide robustness tests. First, we use the R&D stock weighted by the capital stock as an alternative outcome variable. This stock measure is more reflective of the firm's long-term R&D strategy and less sensitive to annual changes than the flow measure R&D intensity. Nonetheless, our results are confirmed as we find a negative instantaneous effect, significant at the 5% level, and positive but insignificant lagged effects. Second, we re-estimate our original specification but exclude nonmanufacturing firms. Again, our results are confirmed as we find a negative instantaneous effect, significant at the 1% level, and positive but insignificant effects in the following periods. In summary, our robustness tests confirm instantaneous crowding-out and insignificant lagged effects.
In the remainder, we report further investigations in Table 10 and calculate the magnitude of crowding-out. First, we examine whether treatment effectiveness of repeated recipients differs from recipients who have not received R&D subsidies throughout the last 2 years.
Since our matching routine imposes an exact match of stratification criteria, we can split the sample accordingly. Indeed, we confirm a negative effect for firms who have not received R&D subsidies throughout the last 2 years, significant at the 5% level, but a negative and insignificant effect for repeated recipients. This difference in effectiveness is in line with
Aschhof (2009) and Hussinger (2008) who report an increase of effectiveness for repeated receivers in Germany. In the Chinese context, this finding suggests that continuous grants do not substitute own R&D expenditures of firms but are used for additional R&D projects.
Next, we consider if the target recipients of China's R&D programs, inventive and hightech firms, experience a higher effectiveness of treatment. As before, we split the sample between inventors and non-inventors and re-estimate our standard specification. However, we fail to confirm a difference since both coefficients are negative and significant at the 10% level. We perform the same exercise for high-tech and non-high-tech firms. For the latter group, we find a negative treatment effect, significant at the 5% level, suggesting crowdingout. Nonetheless, we find no significant effect for high-tech firms and conclude neutrality.
This result suggests a comparatively better use of grants and is quite plausible since the competitiveness of high-tech oriented firms largely depends on R&D and makes these firms more likely to invest R&D grants in additional R&D projects instead of scaling down own R&D.
Finally, we investigate implications of ownership. We find negative and significant effects, at the 5% level, for private-owned firms and majority state-owned firms. In contrast, we identify neutrality effects for minority state-owned firms. These findings are largely in line with our previous considerations and suggest again that minority state-owned firms are indeed superior recipients in comparison to the other ownership types. For repeated recipients, high-tech firms, and minority state-owned firms R&D subsidies have an insignificant effect on firms' own R&D investments. To a large extend, these firm characteristics reflect those characteristics that seem influential in the allocation of grants.
With respect to policy implications of our findings the government should continuously allocate grants to firms in order to enhance grant effectiveness. The targeted allocation of grants to high-tech firms and minority state-owned firms is reasonable. However, the effectiveness of China's R&D subsidies could potentially be improved by requiring a more rigorous matching of public funds with own funds -as prevalent in international best practice.
In conclusion, the overall economic justification for China's R&D programs throughout the time period 2001 to 2006 is questionable since we fail to identify additionality effects of R&D grants on firms' own R&D investments. Our findings are affirmative to the more general observation by Hu & Jefferson (2008) that the influence of government grants on China's industrial R&D is most likely not significant. In addition, in 2012 China's intensity of industrial R&D investments to GDP has reached 1.51% while the ratio of gross R&D expenditures to GDP is as high as 1.98% (MOF 2014 , NBS 2014 . This trend is reflected by our firm level data and shows that the incidence of market failure in the production of knowledge may be less severe than in other economies. Against this background, we acknowledge that the "Medium-to Long-term Plan for Science and Technology Development 
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Step 1 Specify and estimate a probit model to obtain the propensity score ˆ( )
P X
Step 2 Restrict the sample to common support: delete all observations on treated firms with probabilities larger than the maximum and smaller than the minimum in the potential control group. (This step is also performed for other covariates that are possibly used in addition to the propensity score as matching arguments)
Step 3 Choose one observation from the subsample of treated firms and delete it from that pool Step 4
Calculate the Mahalanobis distance between this firm and all non-subsidized firms in order to find the most similar control observation.
where Ω is the empirical covariance matrix of the matching arguments based on the sample of potential controls. We use caliper matching, first introduced by Cochran and Rubin (1973) . The intuition of caliper matching is to avoid "bad" matches (those for which the value of the matching argument j Z is far from i Z ) by imposing a threshold of the maximum distance allowed between the treated and the control group. That is, a match for firm i is only chosen if
where is a pre-specified tolerance
Step 5 Select the observation with the minimum distance from the remaining control group. (Do not remove the selected controls from the pool of potential controls, so that it can be used again.) If the control group is empty after applying the caliper threshold, the treated firm is dropped from the sample and is not taken into account in the evaluation
Step 6
Repeat steps 3-5 for all observations on subsidized firms
Step 7
Using the matched comparison group, the average effect on the treated can thus be calculated as the mean difference of the matched samples:
the counterfactual for i and T n is the sample size (of treated firms)
Step 8 As we perform sampling with replacement to estimate the counterfactual situation, an ordinary t-statistic on mean differences is biased, because it does not take the appearance of repeated observations into account. Therefore, we have to correct the standard errors in order to draw conclusions on statistical inference. We follow Lechner (2001) Notes: The dependent variable is the binary operationalization of receiving R&D subsidies. ***, **, * indicate statistical significance at the 1, 5, and 10 percent levels. 
